In another in vivo experiment, TCS elicits an anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between tumor suppressor in lung cancer 1 (TSLC1) and class-I MHC-restricted T cell-associated molecule (CRTAM) [55]. The gene discussed is CADM1; the disease is neoplasm.